Overview of therapeutic drug research for COVID-19 in China
文献类型：期刊论文
| 作者 | Li, Heng2,3; Yang, Li3; Liu, Fei-fei2,3; Ma, Xin-na1; He, Pei-lan3; Tang, Wei3 ; Tong, Xian-kun3; Zuo, Jian-ping1,2,3
|
| 刊名 | ACTA PHARMACOLOGICA SINICA
 |
| 出版日期 | 2020-06-17 |
| 页码 | 8 |
| 关键词 | SARS-CoV-2 COVID-19 novel coronavirus pneumonia therapeutic drugs anti-SARS-CoV-2 agents favipiravir hydroxychloroquine traditional Chinese medicine |
| ISSN号 | 1671-4083 |
| DOI | 10.1038/s41401-020-0438-y |
| 通讯作者 | Tong, Xian-kun(xktong@simm.ac.cn) ; Zuo, Jian-ping(jpzuo@simm.ac.cn) |
| 英文摘要 | Since the outbreak of novel coronavirus pneumonia (COVID-19) in December 2019, more than 2,500,000 people worldwide have been diagnosed with SARS-CoV-2 as of April 22. In response to this epidemic, China has issued seven trial versions of diagnosis and treatment protocol for COVID-19. According to the information that we have collected so far, this article provides an overview of potential therapeutic drugs and compounds with much attention, including favipiravir and hydroxychloroquine, as well as traditional Chinese medicine, which have been reported with good clinical treatment effects. Moreover, with further understanding of SARS-CoV-2 virus, new drugs targeting specific SARS-CoV-2 viral components arise and investigations on these novel anti-SARS-CoV-2 agents are also reviewed. |
| WOS关键词 | ACUTE RESPIRATORY SYNDROME ; CORONAVIRUS REPLICATION ; CHEMICAL FORMULAS ; SARS-CORONAVIRUS ; LOPINAVIR/RITONAVIR ; CHLOROQUINE ; RIBAVIRIN ; ARBIDOL ; INHIBITORS ; VIRUS |
| WOS研究方向 | Chemistry ; Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:000540983600004 |
| 出版者 | NATURE PUBLISHING GROUP |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/291717]  |
| 专题 | 中国科学院上海药物研究所 |
| 通讯作者 | Tong, Xian-kun; Zuo, Jian-ping |
| 作者单位 | 1.Shanghai Univ Tradit Chinese Med, Lab Immunol & Virol, Shanghai 201203, Peoples R China 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, Shanghai 201203, Peoples R China |
| 推荐引用方式 GB/T 7714 | Li, Heng,Yang, Li,Liu, Fei-fei,et al. Overview of therapeutic drug research for COVID-19 in China[J]. ACTA PHARMACOLOGICA SINICA,2020:8. |
| APA | Li, Heng.,Yang, Li.,Liu, Fei-fei.,Ma, Xin-na.,He, Pei-lan.,...&Zuo, Jian-ping.(2020).Overview of therapeutic drug research for COVID-19 in China.ACTA PHARMACOLOGICA SINICA,8. |
| MLA | Li, Heng,et al."Overview of therapeutic drug research for COVID-19 in China".ACTA PHARMACOLOGICA SINICA (2020):8. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。